Annual Accounts Payable
$4.82 M
+$900.00 K+22.98%
31 December 2023
Summary:
Lyell Immunopharma annual accounts payable is currently $4.82 million, with the most recent change of +$900.00 thousand (+22.98%) on 31 December 2023. During the last 3 years, it has fallen by -$4.58 million (-48.73%). LYEL annual accounts payable is now -48.73% below its all-time high of $9.40 million, reached on 31 December 2020.LYEL Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$3.60 M
-$603.00 K-14.36%
30 September 2024
Summary:
Lyell Immunopharma quarterly accounts payable is currently $3.60 million, with the most recent change of -$603.00 thousand (-14.36%) on 30 September 2024. Over the past year, it has dropped by -$769.00 thousand (-17.62%). LYEL quarterly accounts payable is now -61.73% below its all-time high of $9.40 million, reached on 01 December 2020.LYEL Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LYEL Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +23.0% | -17.6% |
| 3 y3 years | -48.7% | +2.0% |
| 5 y5 years | - | - |
LYEL Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -48.7% | +50.2% | -44.8% | +12.1% |
| 5 y | 5 years | -48.7% | +69.4% | -61.7% | +12.1% |
| alltime | all time | -48.7% | +69.4% | -61.7% | +12.1% |
Lyell Immunopharma Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $3.60 M(-14.4%) |
| June 2024 | - | $4.20 M(-14.2%) |
| Mar 2024 | - | $4.89 M(+1.6%) |
| Dec 2023 | $4.82 M(+23.0%) | $4.82 M(+10.4%) |
| Sept 2023 | - | $4.37 M(-24.8%) |
| June 2023 | - | $5.80 M(+1.3%) |
| Mar 2023 | - | $5.73 M(+46.4%) |
| Dec 2022 | $3.92 M | $3.92 M(-18.3%) |
| Sept 2022 | - | $4.79 M(+12.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2022 | - | $4.25 M(-34.8%) |
| Mar 2022 | - | $6.51 M(+103.0%) |
| Dec 2021 | $3.21 M(-65.9%) | $3.21 M(-9.0%) |
| Sept 2021 | - | $3.53 M(-27.5%) |
| June 2021 | - | $4.86 M(-31.7%) |
| Mar 2021 | - | $7.12 M(-24.2%) |
| Dec 2020 | $9.40 M(+230.4%) | - |
| Dec 2020 | - | $9.40 M |
| Dec 2019 | $2.84 M | - |
FAQ
- What is Lyell Immunopharma annual accounts payable?
- What is the all time high annual accounts payable for Lyell Immunopharma?
- What is Lyell Immunopharma annual accounts payable year-on-year change?
- What is Lyell Immunopharma quarterly accounts payable?
- What is the all time high quarterly accounts payable for Lyell Immunopharma?
- What is Lyell Immunopharma quarterly accounts payable year-on-year change?
What is Lyell Immunopharma annual accounts payable?
The current annual accounts payable of LYEL is $4.82 M
What is the all time high annual accounts payable for Lyell Immunopharma?
Lyell Immunopharma all-time high annual accounts payable is $9.40 M
What is Lyell Immunopharma annual accounts payable year-on-year change?
Over the past year, LYEL annual accounts payable has changed by +$900.00 K (+22.98%)
What is Lyell Immunopharma quarterly accounts payable?
The current quarterly accounts payable of LYEL is $3.60 M
What is the all time high quarterly accounts payable for Lyell Immunopharma?
Lyell Immunopharma all-time high quarterly accounts payable is $9.40 M
What is Lyell Immunopharma quarterly accounts payable year-on-year change?
Over the past year, LYEL quarterly accounts payable has changed by -$769.00 K (-17.62%)